Hospital for Special Surgery Shoulder Arthroplasty Cohort

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Hospital for Special Surgery, New York
Sponsor:
Information provided by (Responsible Party):
Dr. Lisa Mandl, Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier:
NCT00527839
First received: September 7, 2007
Last updated: February 11, 2013
Last verified: February 2013

September 7, 2007
February 11, 2013
April 2007
April 2017   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00527839 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Hospital for Special Surgery Shoulder Arthroplasty Cohort
Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Shoulder Arthroplasty Cohort

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes.

HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here.

The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Not Provided
Observational
Observational Model: Cohort
Not Provided
Not Provided
Non-Probability Sample

We will be asking all patients undergoing a total shoulder arthroplasty to participate.

Shoulder Arthroplasty
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
250
April 2017
April 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years or older and undergoing total shoulder arthroplasty at HSS

Exclusion Criteria:

  • No other exclusion criteria. Pregnant women are eligible for the registry as this is a non-interventional study which only involves filling out questionnaires.
Both
18 Years and older
No
Contact: Robert Marx, MD 212-606-1645
Contact: Kaitlyn Lillemoe, BA 212-606-1866 lillemoek@hss.edu
United States
 
NCT00527839
26117
Yes
Dr. Lisa Mandl, Hospital for Special Surgery, New York
Hospital for Special Surgery, New York
Not Provided
Principal Investigator: Robert Marx, MD Hospital for Special Surgery, New York
Hospital for Special Surgery, New York
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP